Clinical pathophysiology of persistent pulmonary hypertension of the newborn and the role of inhaled nitric oxide therapy

Journal of Perinatology

Volumn 16, Issue PART 2, 1996, Pages

  Kinsella, John P ^a  

^a CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE;

ANIMAL; DRUG EFFECT; HUMAN; INHALATIONAL DRUG ADMINISTRATION; NEWBORN; PATHOPHYSIOLOGY; PERSISTENT FETUS CIRCULATION; PHYSIOLOGY; REVIEW; VASCULAR RESISTANCE; VASODILATATION;

ADMINISTRATION, INHALATION; ANIMALS; ANIMALS, NEWBORN; HUMANS; INFANT, NEWBORN; NITRIC OXIDE; PERSISTENT FETAL CIRCULATION SYNDROME; VASCULAR RESISTANCE; VASODILATION;

EID: 0030103050     PISSN: 07438346     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (2)

1. Gersony WM, Duc GV, Sinclair JC. "PFC" syndrome (persistence of the fetal circulation). Circulation 1969;40(suppl 3):87.
2. Gersony WM. Neonatal pulmonary hypertension: pathophysiology, classification and etiology. Clin Perinatol 1984;11:517-24.